Revenue: The sum of all revenue fields included for a company's operating activities.
Design Therapeutics, Inc. (DSGN) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-17.71M |
|
-- |
|
-- |
|
$20.42M |
|
$-20.42M |
|
$2.70M |
|
$-17.71M |
|
$-17.71M |
|
$-17.71M |
|
$-17.71M |
|
$-17.71M |
|
$-17.71M |
|
$-20.42M |
|
$-21.32M |
|
56.76M |
|
56.76M |
|
$-0.31 |
|
$-0.31 |
|
| Balance Sheet Financials | |
$233.64M |
|
$1.38M |
|
$3.83M |
|
$237.47M |
|
$8.24M |
|
-- |
|
$1.32M |
|
$9.56M |
|
$227.92M |
|
$227.92M |
|
$227.92M |
|
56.77M |
|
| Cash Flow Statement Financials | |
$-16.79M |
|
$7.87M |
|
$0.02M |
|
$22.56M |
|
$13.67M |
|
$-8.90M |
|
$3.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
28.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.86M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.77% |
|
-7.77% |
|
-7.46% |
|
-7.77% |
|
$4.01 |
|
$-0.30 |
|
$-0.30 |
|